600 related articles for article (PubMed ID: 19743626)
1. A case of lepromatous leprosy with multiple relapses.
Hulmani M; Marne RB; Dandakeri S
Lepr Rev; 2009 Jun; 80(2):210-4. PubMed ID: 19743626
[TBL] [Abstract][Full Text] [Related]
2. Two microbiological relapses in a patient with lepromatous leprosy.
Chakma JK; Girdhar A; Natrajan M; Kumar A; Girdhar BK
Lepr Rev; 2008 Sep; 79(3):331-4. PubMed ID: 19009984
[TBL] [Abstract][Full Text] [Related]
3. Persistence of lepromatous granuloma in clinically cured cases of leprosy.
Desikan P; Desikan KV
Int J Lepr Other Mycobact Dis; 1995 Sep; 63(3):417-21. PubMed ID: 7594925
[TBL] [Abstract][Full Text] [Related]
4. Incidence of late lepra reaction among multibacillary leprosy patients after MDT.
Vijayakumaran P; Manimozhi N; Jesudasan K
Int J Lepr Other Mycobact Dis; 1995 Mar; 63(1):18-22. PubMed ID: 7730714
[TBL] [Abstract][Full Text] [Related]
5. Relapse of lepromatous leprosy after WHO/MDT with rapid bacterial growth.
Oliveira ML; Pierro AP; Silveira PA; Campos MM; Vilela MF
Lepr Rev; 2002 Dec; 73(4):386-8. PubMed ID: 12549846
[TBL] [Abstract][Full Text] [Related]
6. Relapses during long-term follow up with drug-susceptible M. leprae among multibacillary leprosy patients treated with multidrug therapy regimens; case reports.
Thomas A; Hari L; Nagarajan M; Prabhakar R
Int J Lepr Other Mycobact Dis; 1995 Sep; 63(3):391-4. PubMed ID: 7594922
[TBL] [Abstract][Full Text] [Related]
7. Relapse as histoid leprosy after receiving multidrug therapy (MDT); a report of three cases.
Shaw IN; Ebenezer G; Rao GS; Natrajan MM; Balasundaram B
Int J Lepr Other Mycobact Dis; 2000 Sep; 68(3):272-6. PubMed ID: 11221089
[TBL] [Abstract][Full Text] [Related]
8. Studies on risk of leprosy relapses in China: relapses after treatment with multidrug therapy.
Chen XS; Li WZ; Jiang C; Ye GY
Int J Lepr Other Mycobact Dis; 1999 Dec; 67(4):379-87. PubMed ID: 10700911
[TBL] [Abstract][Full Text] [Related]
9. The relapse rate in MB leprosy patients treated with 2-years of WHO-MDT is not low.
Gelber RH; Balagon VF; Cellona RV
Int J Lepr Other Mycobact Dis; 2004 Dec; 72(4):493-500. PubMed ID: 15755209
[TBL] [Abstract][Full Text] [Related]
10. Reversal reaction and Mitsuda conversion in polar lepromatous leprosy: a case report.
Kar BR; Job CK
Lepr Rev; 2005 Sep; 76(3):258-62. PubMed ID: 16248213
[TBL] [Abstract][Full Text] [Related]
11. Relapses in multibacillary leprosy patients after multidrug therapy.
Poojabylaiah M; Marne RB; Varikkodan R; Bala N; Dandakeri S; Martis J
Lepr Rev; 2008 Sep; 79(3):320-4. PubMed ID: 19009982
[TBL] [Abstract][Full Text] [Related]
12. Comparative evaluation of immunotherapeutic efficacy of BCG and mw vaccines in patients of borderline lepromatous and lepromatous leprosy.
Narang T; Kaur I; Kumar B; Radotra BD; Dogra S
Int J Lepr Other Mycobact Dis; 2005 Jun; 73(2):105-14. PubMed ID: 16830653
[TBL] [Abstract][Full Text] [Related]
13. Relapses in multibacillary patients treated with multi-drug therapy until smear negativity: findings after twenty years.
Norman G; Joseph G; Richard J
Int J Lepr Other Mycobact Dis; 2004 Mar; 72(1):1-7. PubMed ID: 15217321
[TBL] [Abstract][Full Text] [Related]
14. Involvement of genitofemoral nerve with genital lesions in lepromatous leprosy.
Agrawal SK; Singal A; Pandhi D; Oberoi S
Indian J Lepr; 2004; 76(1):71-7. PubMed ID: 15527060
[TBL] [Abstract][Full Text] [Related]
15. Relapses in multibacillary leprosy patients after stopping treatment with rifampin-containing combined regimens. Marchoux Chemotherapy Study Group.
Jamet P; Ji B
Int J Lepr Other Mycobact Dis; 1992 Dec; 60(4):525-35. PubMed ID: 1299707
[TBL] [Abstract][Full Text] [Related]
16. Lepromatous leprosy.
Booth AV; Kovich OI
Dermatol Online J; 2007 Jan; 13(1):9. PubMed ID: 17511942
[TBL] [Abstract][Full Text] [Related]
17. Wade's histoid leprosy: three clinical presentations.
Pereyra SB; Danielo CA; Ponssa GJ; Consigli JE; Papa MB; Ghirardi G
Int J Dermatol; 2007 Sep; 46(9):944-6. PubMed ID: 17822497
[TBL] [Abstract][Full Text] [Related]
18. Viability of Mycobacterium leprae in lepromatous patients after five years of dapsone monotherapy supplemented with two years of multidrug therapy.
Sivaprasad N; Snehalatha S; Lobo D; Aschhoff M; Job CK
Indian J Lepr; 1995; 67(4):427-33. PubMed ID: 8849919
[TBL] [Abstract][Full Text] [Related]
19. Long-term efficacy of 2 year WHO multiple drug therapy (MDT) in multibacillary (MB) leprosy patients.
Cellona RV; Balagon MF; dela Cruz EC; Burgos JA; Abalos RM; Walsh GP; Topolski R; Gelber RH; Walsh DS
Int J Lepr Other Mycobact Dis; 2003 Dec; 71(4):308-19. PubMed ID: 14763888
[TBL] [Abstract][Full Text] [Related]
20. Skin patches heralding relapse in a treated case of neuritic leprosy.
Singh G; Dash K; Grover S; Sangolli P
Lepr Rev; 1998 Dec; 69(4):400-1. PubMed ID: 9927814
[No Abstract] [Full Text] [Related]
[Next] [New Search]
